In-Vivo Effects Of Aloe - Emodin On Nude Mice: Glioma Xenografts
- 2002 Grant = $20,000
- 2003 Grant = $25,000
- 2004 Grant = $20,000
In April 2002, the aloe institute embarked on a long-term aloe/cancer project with an experienced doctor and researcher, Dr. Mildred Acevedo-Duncan, located at the University Of South Florida in Tampa.
Dr. Acevedo-Duncan believes a substance in the yellow aloe sap, aloe-emodin, may have properties that will selectively kill brain tumor cancer cells without harming good brain cells.
Now with over one year in her research, the results are very exciting and she is repeating the experiment at least three more times with U-37M6 Glioma (brain cancer) cells and normal SV6 brain cells.
Dr. Acevedo-Duncan is also reinvestigating the effects of aloe-emodin on Protein Kinase C activity in U-373mg Glioma cells and normal brain cells when applied.
With this long-term project, perhaps 4-5 years, the aloe institute may continue its grants to Dr. Acevedo-Duncan as her experiments continue to produce promising results.
2004-continued supporting the brain cancer work of Dr. Mildred Duncan and she continues to find positive results on her work with aloe emodin. The results are positive enough to begin additional studies.